[
  {
    "date": "2023-03-30",
    "symbol": "ABTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-03-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--03-31",
    "entityfilenumber": "333-156091",
    "entityregistrantname": "Alterola Biotech, Inc.",
    "entitycentralindexkey": 1442999,
    "entitytaxidentificationnumber": "82-1317032",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "47 Hamilton Square",
    "entityaddresscityortown": "Birkenhead Merseyside",
    "entityaddresscountry": "GB",
    "entityaddresspostalzipcode": "CH415AR",
    "cityareacode": 151,
    "localphonenumber": "601     9477",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "Gries & Associates, LLC",
    "auditorlocation": "Denver, Colorado 80246",
    "auditorfirmid": 6778,
    "cash": 8890,
    "valueaddedtaxreceivable": 37953,
    "deferredincometaxassetsnet": 189355,
    "inventorynet": 986,
    "assetscurrent": 237184,
    "intangibleassetscurrent": 12139779,
    "assets": 12376963,
    "accountspayablecurrent": 611805,
    "accruedliabilitiescurrent": 254864,
    "loanspayablecurrent": 1260434,
    "liabilitiescurrent": 2127103,
    "convertiblenotespayablecurrent": 154313,
    "liabilities": 2281416,
    "commonstockvalue": 807048,
    "additionalpaidincapital": 18927919,
    "retainedearningsaccumulateddeficit": -9576247,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -63173,
    "stockholdersequity": 10095547,
    "liabilitiesandstockholdersequity": 12376963,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 2000000000,
    "commonstocksharesoutstanding": 807047948,
    "accountingandauditfees": 106893,
    "professionalfees": 363944,
    "researchanddevelopmentexpense": 46422,
    "legalfees": 179940,
    "noninterestexpensedirectorsfees": 347362,
    "consultingfees": 443073,
    "salariesandwages": 140409,
    "generalandadministrativeexpense": 68938,
    "operatingexpenses": 1896981,
    "operatingincomeloss": -1896981,
    "currentincometaxexpensebenefit": -154524,
    "netincomeloss": -1742457,
    "weightedaveragenumberofshareoutstandingbasic": 806332740,
    "sharesissued": 807047948,
    "stockissuedduringperiodvalueother": 280,
    "stockissuedduringperiodsharesother": 280000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -77772,
    "stockissuedduringperiodvaluenewissues": 385,
    "stockissuedduringperiodsharesnewissues": 384615,
    "stockissuedduringperiodvalueissuedforservices": 1500,
    "stockissuedduringperiodsharesissuedforservices": 1500000,
    "stockissuedduringperiodvalueemployeebenefitplan": 2250,
    "stockissuedduringperiodsharesemployeebenefitplan": 2250000,
    "proceedsfromissuanceofcommonstock": 802500,
    "valuationallowancedeferredtaxassetchangeinamount": -189535,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentbeforetaxportionattributabletononcontrollinginterest": 136721,
    "increaseinfundsinattorneytrustaccount": 12409,
    "increasedecreaseinvattaxesreceivable": 12733,
    "deferredothertaxexpensebenefit": 12409,
    "increasedecreaseinaccountspayable": 69295,
    "increasedecreaseinaccruedliabilities": -141638,
    "netcashprovidedbyusedinoperatingactivities": -1039792,
    "increasedecreaseinintangibleassetscurrent": -139799,
    "netcashprovidedbyusedininvestingactivities": -139799,
    "proceedsfromissuanceorsaleofequity": 50295,
    "proceedsfromrelatedpartydebt": -1164964,
    "netcashprovidedbyusedinfinancingactivities": 1212159,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 32689,
    "foreigncurrencytransactiongainlossexcludinginvestmentpricechangeaftertax": -87615,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8890,
    "accruedprofessionalfeescurrent": 15000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 0.001,
    "commonstocksharesissued": 807047948,
    "shareholderadvances": 1260434,
    "debtinstrumentdescription": "Theseadvances are non â€“ interest bearing and have no specified terms of repayment",
    "capital": 1890623
  },
  {
    "date": "2022-03-30",
    "symbol": "ABTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2022-03-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--03-31",
    "entityfilenumber": "333-156091",
    "entityregistrantname": "Alterola Biotech, Inc.",
    "entitycentralindexkey": 1442999,
    "entitytaxidentificationnumber": "82-1317032",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "47 Hamilton Squar",
    "entityaddresscityortown": "Birkenhead Merseyside",
    "entityaddresscountry": "GB",
    "entityaddresspostalzipcode": "CH415AR",
    "cityareacode": 151,
    "localphonenumber": "601     9477",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "auditorname": "Gries & Associates, LLC",
    "auditorlocation": "Denver, Colorado 80246",
    "auditorfirmid": 6778,
    "cash": 63816,
    "fundsheldunderreinsuranceagreementsasset": 12409,
    "valueaddedtaxreceivable": 50686,
    "inventorynet": 1050,
    "assetscurrent": 127961,
    "intangibleassetscurrent": 12000000,
    "assets": 12127961,
    "accountspayablecurrent": 542510,
    "accruedliabilitiescurrent": 396486,
    "duetorelatedpartiescurrentandnoncurrent": 98470,
    "convertiblenotespayablecurrent": 164220,
    "liabilitiescurrent": 1201685,
    "liabilities": 1201685,
    "commonstockvalue": 802633,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": 14599,
    "additionalpaidincapital": 18079554,
    "retainedearningsaccumulateddeficit": -7970510,
    "stockholdersequity": 10926276,
    "liabilitiesandstockholdersequity": 12127961,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 2000000000,
    "commonstocksharesoutstanding": 802633333,
    "commonstocksharesissued": 802633333,
    "accountingandauditfees": 133036,
    "researchanddevelopmentexpense": 2432210,
    "professionalfees": 341286,
    "legalfees": 38248,
    "noninterestexpensedirectorsfees": 82913,
    "consultingfees": 3155593,
    "salariesandwages": 194643,
    "generalandadministrativeexpense": 93206,
    "operatingexpenses": 6471134,
    "operatingincomeloss": -6471134,
    "netincomeloss": -6471134,
    "weightedaveragenumberofshareoutstandingbasic": 769967671,
    "sharesissued": 802633333,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 28622,
    "stockissuedduringperiodvaluenewissues": 853,
    "stockissuedduringperiodsharesnewissues": 853333,
    "stockissuedduringperiodvalueacquisitions": 24000,
    "stockissuedduringperiodsharesacquisitions": 24000000,
    "stockissuedduringperiodvalues1registration": 7500,
    "stockissuedduringperiodsharess1registration": 7500000,
    "stockissuedduringperiodvalueissuedforservices": 16000,
    "stockissuedduringperiodsharesissuedforservices": 16000000,
    "proceedsfromissuanceofcommonstock": 5759250,
    "increasedecreaseininventories": -1050,
    "increaseinfundsinattorneytrustaccount": -12409,
    "increasedecreaseinaccountsreceivable": -50686,
    "increasedecreaseinaccruedliabilities": 376242,
    "increasedecreaseinaccountspayable": 444131,
    "netcashprovidedbyusedinoperatingactivities": 44344,
    "proceedsfromnotespayable": 164220,
    "proceedsfromissuanceorsaleofequity": 368657,
    "proceedsfromrelatedpartydebt": 542545,
    "netcashprovidedbyusedinfinancingactivities": -9669,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsdisposalgroupincludingdiscontinuedoperations": 28622,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 34675,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 63817,
    "accruedprofessionalfeescurrent": 32687,
    "shareholderadvances": 98470,
    "capital": 909504
  },
  {
    "date": "2020-09-29",
    "symbol": "ABTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "333-156091",
    "entityregistrantname": "Alterola Biotech Inc.",
    "entitycentralindexkey": 1442999,
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "fundsheldunderreinsuranceagreementsasset": 15273,
    "assetscurrent": 15273,
    "assets": 15273,
    "accruedliabilitiescurrent": 36244,
    "accruedbonusescurrent": 300000,
    "duetorelatedpartiescurrentandnoncurrent": 2250,
    "liabilitiescurrent": 338494,
    "liabilities": 338494,
    "commonstockvalue": 129980,
    "additionalpaidincapital": 768587,
    "retainedearningsaccumulateddeficit": -1221788,
    "stockholdersequity": -1221788,
    "liabilitiesandstockholdersequity": 15273,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 140000000,
    "commonstocksharesissued": 129980000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "sharebasedcompensation": 130000,
    "accountingandauditfees": 11000,
    "professionalfees": 60000,
    "legalfees": 4034,
    "noninterestexpensedirectorsfees": 120000,
    "generalandadministrativeexpense": 4477,
    "operatingexpenses": 329511,
    "operatingincomeloss": -329511,
    "gainlossonsaleofotherassets": 79000,
    "othernonoperatingincomeexpense": 79000,
    "netincomelossavailabletocommonstockholdersbasic": -250511,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 118063333,
    "sharesissued": 129980000,
    "stockissuedduringperiodsharesissuedforservices": 13000000,
    "stockissuedduringperiodvalueissuedforservices": 130000,
    "netincomeloss": -250511,
    "increasedecreaseinaccruedliabilities": 121042,
    "increasedecreasefundsheldintrustwithattorney": -531,
    "entityincorporationdateofincorporation": "2008-07-21",
    "accruedauditfeescurrent": 10000,
    "accruedaccountingfeescurrent": 6600,
    "accruedprofessionalfeescurrent": 19644,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 63000,
    "currentfederaltaxexpensebenefit": -85174,
    "deferredtaxassetsotherlosscarryforwards": 85174,
    "incometaxexpensebenefit": 85174,
    "taxcreditcarryforwardvaluationallowance": 85174,
    "deferredtaxassetsoperatinglosscarryforwards": 433172,
    "deferredtaxassetsgross": 433172,
    "deferredtaxassetsvaluationallowance": 433172,
    "operatinglosscarryforwards": 1274034,
    "managementfeepayable": 300000,
    "capital": 323221,
    "otherincome": 79000
  },
  {
    "date": "2019-09-29",
    "symbol": "ABTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "333-156091",
    "entityregistrantname": "Alterola Biotech Inc.",
    "entitycentralindexkey": 1442999,
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "fundsheldunderreinsuranceagreementsasset": 14742,
    "assets": 14742,
    "accruedbonusescurrent": 180000,
    "duefromrelatedpartiescurrent": 2250,
    "liabilitiescurrent": 217452,
    "liabilities": 217452,
    "commonstockvalue": 116980,
    "additionalpaidincapital": 651587,
    "retainedearningsaccumulateddeficit": -971277,
    "stockholdersequity": -971277,
    "liabilitiesandstockholdersequity": 14742,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 140000000,
    "commonstocksharesissued": 116980000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "sharebasedcompensation": 126000,
    "accountingandauditfees": 11000,
    "legalfees": 930,
    "noninterestexpensedirectorsfees": 180000,
    "generalandadministrativeexpense": 523,
    "operatingexpenses": 258453,
    "operatingincomeloss": -258453,
    "interestexpense": 249,
    "othernonoperatingincomeexpense": -249,
    "netincomelossavailabletocommonstockholdersbasic": -258702,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 116563333,
    "sharesissued": 116980000,
    "stockissuedduringperiodsharesissuedforservices": 1000000,
    "stockissuedduringperiodvalueissuedforservices": 89000,
    "proceedsfromcontributedcapital": 21559,
    "netincomeloss": -258702,
    "increasedecreaseinaccruedliabilities": 130953,
    "increasedecreaseinaccruedinterestreceivablenet": 249,
    "increasedecreaseinduetorelatedparties": 1500,
    "entityincorporationdateofincorporation": "2008-07-21",
    "debtconversionoriginaldebtduedateofdebtdaymonthandyear": "2023-04-25",
    "debtinstrumentinterestratestatedpercentage": 0.05,
    "deferreddiscountsfinancechargesandinterestincludedinreceivables": 1500,
    "debtinstrumentdecreaseforgiveness": 282178,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 63000,
    "currentfederaltaxexpensebenefit": -82472,
    "deferredtaxassetsotherlosscarryforwards": 82472,
    "incometaxexpensebenefit": 82472,
    "taxcreditcarryforwardvaluationallowance": 82472,
    "deferredtaxassetsoperatinglosscarryforwards": 342511,
    "deferredtaxassetsgross": 342511,
    "deferredtaxassetsvaluationallowance": 342511,
    "operatinglosscarryforwards": 1007385,
    "capital": 202710
  },
  {
    "date": "2018-09-29",
    "symbol": "ABTI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2018,
    "currentfiscalyearenddate": "--09-30",
    "entityfilenumber": "333-156091",
    "entityregistrantname": "Alterola Biotech Inc.",
    "entitycentralindexkey": 1442999,
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "fundsheldunderreinsuranceagreementsasset": 14742,
    "deferredcompensationequity": 36000,
    "assetscurrent": 50742,
    "assets": 50742,
    "accruedliabilitiescurrent": 24249,
    "depositliabilitiesaccruedinterest": 1360,
    "accruedbonusescurrent": 60000,
    "duefromrelatedpartiescurrent": 750,
    "liabilitiescurrent": 86359,
    "longtermdebtnoncurrent": 19950,
    "liabilities": 106309,
    "commonstockvalue": 115980,
    "additionalpaidincapital": 541028,
    "retainedearningsaccumulateddeficit": -712575,
    "stockholdersequity": -712575,
    "liabilitiesandstockholdersequity": 50742,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 140000000,
    "commonstocksharesissued": 115980000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "sharebasedcompensation": 54000,
    "accountingandauditfees": 1000,
    "legalfees": 7208,
    "noninterestexpensedirectorsfees": 60000,
    "generalandadministrativeexpense": 349,
    "operatingexpenses": 122557,
    "operatingincomeloss": -122557,
    "interestexpense": 10510,
    "othernonoperatingincomeexpense": -10510,
    "netincomelossavailabletocommonstockholdersbasic": -133067,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 115617308,
    "sharesissued": 115980000,
    "stockissuedduringperiodsharesissuedforservices": 1000000,
    "stockissuedduringperiodvalueissuedforservices": 89000,
    "proceedsfromcontributedcapital": 282178,
    "netincomeloss": -133067,
    "increasedecreaseinaccruedliabilities": 63349,
    "increasedecreaseinaccruedinterestreceivablenet": 10510,
    "increasedecreasefundsheldintrustwithattorney": -14742,
    "netcashprovidedbyusedinoperatingactivities": -19950,
    "proceedsfromnotespayable": 19950,
    "netcashprovidedbyusedinfinancingactivities": 19950,
    "increasedecreaseindeferredcompensation": 36000,
    "entityincorporationdateofincorporation": "2008-07-21",
    "increasedecreaseinprepaidexpense": 36000,
    "accruedauditfeescurrent": 1000,
    "accruedaccountingfeescurrent": 4350,
    "accruedprofessionalfeescurrent": 18899,
    "convertiblenotespayable": 19950,
    "debtconversionoriginaldebtduedateofdebtdaymonthandyear": "2023-04-25",
    "debtinstrumentinterestratestatedpercentage": 0.05,
    "deferreddiscountsfinancechargesandinterestincludedinreceivables": 1500,
    "debtinstrumentdecreaseforgiveness": 282178,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 63000,
    "currentfederaltaxexpensebenefit": -45243,
    "currentfederalstateandlocaltaxexpensebenefit": -45243,
    "incometaxexpensebenefit": 45243,
    "taxcreditcarryforwardvaluationallowance": 45243,
    "deferredtaxassetsoperatinglosscarryforwards": 260039,
    "deferredtaxassetsgross": 260039,
    "deferredtaxassetsvaluationallowance": 260039,
    "operatinglosscarryforwards": 482643
  }
]